跳至主要内容
临床试验/NL-OMON54024
NL-OMON54024招募中4 期

GAG-therapy Efficacy Trial Solution for Bladder pain syndrome/ Interstitial cystitis - GETSBI study

Radboud Universitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1) Adult patients (18 yrs or older) with symptomatic BPS with established
  • Hunner lesions objectified with urethrocystoscopy in the 3 months prior to
  • 2) A VAS pain score (maximum pain during the last 3 days; scale 0-10) of at

排除标准

  • 1) pain, discomfort in pelvic region of inflammatory bladder conditions due to
  • any cause other than BPS with Hunner lesions, 2) a urine tract infection in the
  • previous 6 weeks 3) received bladder instillations for BPS in the previous 3
  • months 4) received intradetrusor Botulinum toxin (BOTOX) injections within the
  • previous 12 months 5) received transurethral coagulation/ablation therapy of
  • Hunner lesions within the last 12 months 6) started a new treatment for
  • (chronic) pain (pharmacotherapy) or urine tract infection in the last month. 7)
  • Unable (also legal) to give informed consent. 8) Allergy/Sensibilisation for
  • artificial tears (this will be tested by applying one drop in one eye).

研究者

相似试验

GAG-therapy Efficacy Trial Solution for Bladder pain... | 临床试验